SuperSonic Imagine to Present Newly Upgraded Aixplorer(R) Ultrasound Platform at JFR in Paris - Seite 3

ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI. For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

Contact information:

SuperSonic Imagine
Bernard Doorenbos
CEO
Email Contact
[phone]

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
Email Contact
[phone]

NewCap
Investor Relations - EU
Pierre Laurent / Florent Alba
Email Contact
[phone]

Pascale Communication
Media Relations - US
Amy Phillips
Email Contact
[phone]